A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
Astellas Pharma Inc
Mayo Clinic
Genmab
Ocellaris Pharma, Inc.
Tanabe Pharma America, Inc.
ITM Oncologics GmbH
Incyte Corporation
NuCana plc
OncoC4, Inc.
Klus Pharma Inc.
RAPT Therapeutics, Inc.
Cybrexa Therapeutics
Salubris Biotherapeutics Inc
NextCure, Inc.
pharmaand GmbH
Fred Hutchinson Cancer Center
Nektar Therapeutics
Institut Bergonié
Rubius Therapeutics
Incyte Corporation
Silverback Therapeutics
Incyte Corporation